Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

$7.5m stretches reach of OrthoScan's Mini-C Arm

This article was originally published in Clinica

  • News

Executive Summary

Scottsdale, Arizona-based OrthoScan is to expand US and international sales coverage of its lead product, the Mini-C Arm for fluoroscopic imaging of the extremities, with the $7.5m it raised in a recent series B financing. The funding round was led by River Cities Capital Fund (RCCF), with contributions from OrthoScan's existing shareholders Aphelion Capital, California Technology Ventures and a group of private investors. The Mini-C Arm sold by OrthoScan offers and improved image resolution and is a smaller and lighter version of the original system invented by the company's founder, Larry Grossman, in 1982. It is used during orthopaedic surgery and digital diagnostic imaging.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

EU: Good News For IVDs And For Future Transparency Of Medtech Compliance

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

See All
UsernamePublicRestriction

Register

MT041719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By